These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9784130)

  • 1. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.
    Rohrer SP; Birzin ET; Mosley RT; Berk SC; Hutchins SM; Shen DM; Xiong Y; Hayes EC; Parmar RM; Foor F; Mitra SW; Degrado SJ; Shu M; Klopp JM; Cai SJ; Blake A; Chan WW; Pasternak A; Yang L; Patchett AA; Smith RG; Chapman KT; Schaeffer JM
    Science; 1998 Oct; 282(5389):737-40. PubMed ID: 9784130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of subtype selective somatostatin receptor agonists.
    Rohrer SP; Schaeffer JM
    J Physiol Paris; 2000; 94(3-4):211-5. PubMed ID: 11087999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rapid identification of subtype-selected agonists of the somatostatin receptor through combinatorial chemistry].
    Habashita H
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1810-1. PubMed ID: 18051437
    [No Abstract]   [Full Text] [Related]  

  • 4. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice.
    Strowski MZ; Parmar RM; Blake AD; Schaeffer JM
    Endocrinology; 2000 Jan; 141(1):111-7. PubMed ID: 10614629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonist.
    Strowski MZ; Cashen DE; Birzin ET; Yang L; Singh V; Jacks TM; Nowak KW; Rohrer SP; Patchett AA; Smith RG; Schaeffer JM
    Endocrinology; 2006 Oct; 147(10):4664-73. PubMed ID: 16857751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.
    Singh V; Brendel MD; Zacharias S; Mergler S; Jahr H; Wiedenmann B; Bretzel RG; Plöckinger U; Strowski MZ
    J Clin Endocrinol Metab; 2007 Feb; 92(2):673-80. PubMed ID: 17105845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin inhibits insulin release via SSTR2 in hamster clonal beta-cells and pancreatic islets.
    Yao CY; Gill M; Martens CA; Coy DH; Hsu WH
    Regul Pept; 2005 Jul; 129(1-3):79-84. PubMed ID: 15927701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of somatostatin receptor subtype selective agonists through combinatorial chemistry.
    Rohrer SP; Berk SC
    Curr Opin Drug Discov Devel; 1999 Jul; 2(4):293-303. PubMed ID: 19649957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2.
    Yang L; Berk SC; Rohrer SP; Mosley RT; Guo L; Underwood DJ; Arison BH; Birzin ET; Hayes EC; Mitra SW; Parmar RM; Cheng K; Wu TJ; Butler BS; Foor F; Pasternak A; Pan Y; Silva M; Freidinger RM; Smith RG; Chapman K; Schaeffer JM; Patchett AA
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10836-41. PubMed ID: 9724791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSTR2 mediates the somatostatin-induced increase in intracellular Ca(2+) concentration and insulin secretion in the presence of arginine vasopressin in clonal beta-cell HIT-T15.
    Cheng H; Yibchok-anun S; Coy DH; Hsu WH
    Life Sci; 2002 Jul; 71(8):927-36. PubMed ID: 12084389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Natural peptides and their analogs. XXXV. Synthesis and properties of [Ala5, Orn9]somatostatin].
    Shvachkin IuP; Smirnova AP; Ermak NM; Fedotov VP; Sadovnikova NV
    Bioorg Khim; 1985 Aug; 11(8):1026-36. PubMed ID: 2865960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5.
    Zambre Y; Ling Z; Chen MC; Hou X; Woon CW; Culler M; Taylor JE; Coy DH; Van Schravendijk C; Schuit F; Pipeleers DG; Eizirik DL
    Biochem Pharmacol; 1999 May; 57(10):1159-64. PubMed ID: 11230804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.
    Afargan M; Janson ET; Gelerman G; Rosenfeld R; Ziv O; Karpov O; Wolf A; Bracha M; Shohat D; Liapakis G; Gilon C; Hoffman A; Stephensky D; Oberg K
    Endocrinology; 2001 Jan; 142(1):477-86. PubMed ID: 11145612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis.
    Strowski MZ; Kohler M; Chen HY; Trumbauer ME; Li Z; Szalkowski D; Gopal-Truter S; Fisher JK; Schaeffer JM; Blake AD; Zhang BB; Wilkinson HA
    Mol Endocrinol; 2003 Jan; 17(1):93-106. PubMed ID: 12511609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted expression of somatostatin receptor 3 to primary cilia in the pancreatic islets and adenohypophysis of mice.
    Iwanaga T; Miki T; Takahashi-Iwanaga H
    Biomed Res; 2011 Feb; 32(1):73-81. PubMed ID: 21383513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
    Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET; Sandler S
    Regul Pept; 2007 Jan; 138(1):1-9. PubMed ID: 16935361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic beta-cell somatostatin receptors.
    Thermos K; Meglasson MD; Nelson J; Lounsbury KM; Reisine T
    Am J Physiol; 1990 Aug; 259(2 Pt 1):E216-24. PubMed ID: 1974386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.
    Qader SS; Håkanson R; Rehfeld JF; Lundquist I; Salehi A
    Regul Pept; 2008 Feb; 146(1-3):230-7. PubMed ID: 17942170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
    Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.